S. Russell, K. Peng, and J. Bell, Oncolytic virotherapy, Nature Biotechnology, vol.311, issue.7, pp.658-70, 2012.
DOI : 10.1126/science.1121411

B. Lichty, C. Breitbach, D. Stojdl, and J. Bell, Going viral with cancer immunotherapy, Nature Reviews Cancer, vol.15, issue.8, pp.559-67, 2014.
DOI : 10.1038/sj.cgt.7701105

D. Bartlett, Z. Liu, M. Sathaiah, R. Ravindranathan, Z. Guo et al., Oncolytic viruses as therapeutic cancer vaccines, Molecular Cancer, vol.12, issue.1, p.103, 2013.
DOI : 10.1186/1476-4598-12-103

URL : https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/1476-4598-12-103?site=molecular-cancer.biomedcentral.com

S. Workenhe and K. Mossman, Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies, Molecular Therapy, vol.22, issue.2, pp.251-257, 2014.
DOI : 10.1038/mt.2013.220

P. Coulie, B. Van-den-eynde, P. Van-der-bruggen, and T. Boon, Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy, Nature Reviews Cancer, vol.95, issue.2, pp.135-181, 2014.
DOI : 10.1084/jem.193.10.1189

R. Wang and H. Wang, Immune targets and neoantigens for cancer immunotherapy and precision medicine, Cell Research, vol.15, issue.1, pp.11-37, 2017.
DOI : 10.1038/nrd.2016.201

E. Jager, Y. Chen, J. Drijfhout, J. Karbach, M. Ringhoffer et al., Simultaneous Humoral and Cellular Immune Response against Cancer???Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2???binding Peptide Epitopes, The Journal of Experimental Medicine, vol.157, issue.2, pp.265-70, 1998.
DOI : 10.1097/00008390-199612000-00003

A. Rapoport, E. Stadtmauer, G. Binder-scholl, O. Goloubeva, D. Vogl et al., NY-ESO-1???specific TCR???engineered T cells mediate sustained antigen-specific antitumor effects in myeloma, Nature Medicine, vol.72, issue.8, pp.914-935, 2015.
DOI : 10.1182/blood-2009-04-217604

J. Fonteneau, F. Brilot, C. Munz, and M. Gannage, The Tumor Antigen NY
URL : https://hal.archives-ouvertes.fr/inserm-01285160

C. Munz, Autophagy proteins in antigen processing for presentation on MHC molecules, Immunological Reviews, vol.206, issue.M111, pp.17-27, 2016.
DOI : 10.1084/jem.20082108

J. Foloppe, J. Kintz, N. Futin, A. Findeli, P. Cordier et al., Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer cell, Gene Ther, vol.154, issue.144, pp.1361-71263, 2003.

H. Kambara, H. Okano, E. Chiocca, and Y. Saeki, An Oncolytic HSV-1 Mutant Expressing ICP34.5 under Control of a Nestin Promoter Increases Survival of Animals even when Symptomatic from a Brain Tumor, Cancer Research, vol.65, issue.7, pp.2832-2841, 2005.
DOI : 10.1158/0008-5472.CAN-04-3227

D. Venskus, I. Kalvins, D. Pjanova, R. Petrovska, J. Auzins et al., Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. European patent EP2826856. 18. Coffin RS. From virotherapy to oncolytic immunotherapy: where are we now? Oncolytic immunotherapy: the new clinical outbreak, Curr Opin Virol. Oncoimmunology, vol.135, issue.191, pp.93-100, 2015.

O. Donnelly, F. Errington-mais, L. Steele, E. Hadac, V. Jennings et al., Induction of immunogenic tumor cell death by attenuated oncolytic measles virus Measles virus causes immunogenic cell death in human melanoma, J Clin Cell Immunol, vol.6, issue.21, p.291, 2013.

J. Guillerme, N. Boisgerault, D. Roulois, J. Menager, C. Combredet et al., Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells, Clinical Cancer Research, vol.19, issue.5, pp.1147-58, 2013.
DOI : 10.1158/1078-0432.CCR-12-2733

URL : http://clincancerres.aacrjournals.org/content/clincanres/19/5/1147.full.pdf

E. Galanis, P. Atherton, M. Maurer, K. Knutson, S. Dowdy et al., Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer, Cancer Research, vol.75, issue.1, pp.22-30, 2015.
DOI : 10.1158/0008-5472.CAN-14-2533

URL : http://cancerres.aacrjournals.org/content/canres/75/1/22.full.pdf

J. Heo, T. Reid, L. Ruo, C. Breitbach, S. Rose et al., Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer, Nature Medicine, vol.53, issue.3, pp.329-365, 2013.
DOI : 10.1080/01621459.1958.10501452

R. Andtbacka, M. Ross, I. Puzanov, M. Milhem, F. Collichio et al., Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial, Annals of Surgical Oncology, vol.45, issue.2, pp.4169-77, 2016.
DOI : 10.1016/j.ejca.2008.10.026

H. Vaughan, S. Svobodova, D. Macgregor, S. Sturrock, A. Jungbluth et al., Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1. Clin Cancer Res Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ Tcell clones using peptide pulsed mature dendritic cells, J Clin Oncol. Journal of immunological methods, vol.1034258, issue.2912, pp.8396-4042619, 2001.

F. Davodeau, M. Difilippantonio, E. Roldan, M. Malissen, J. Casanova et al., The tight interallelic positional coincidence that distinguishes T-cell receptor Jalpha usage does not result from homologous chromosomal pairing during ValphaJalpha rearrangement, The EMBO Journal, vol.20, issue.17, pp.4717-4746, 2001.
DOI : 10.1093/emboj/20.17.4717

B. Arden, S. Clark, D. Kabelitz, and T. Mak, Human T-cell receptor variable gene segment families, Immunogenetics, vol.42, issue.6, pp.455-500, 1995.
DOI : 10.1007/BF00172176

C. Combredet, V. Labrousse, L. Mollet, C. Lorin, F. Delebecque et al., A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice, Journal of Virology, vol.77, issue.21, pp.11546-54, 2003.
DOI : 10.1128/JVI.77.21.11546-11554.2003

J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair et al., Fiji: an open-source platform for biological-image analysis, Nature Methods, vol.27, issue.7, pp.676-82, 2012.
DOI : 10.1093/bioinformatics/btr390

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855844/pdf

V. Annexin, or PI+ cells was measured by flow cytometry. Indicated values are means ± SEM of three independent experiments